Yes-Associated Protein 1 Exhibits Oncogenic Property in Gastric Cancer and Its Nuclear Accumulation Associates with Poor Prognosis
Cited by 258
Related Papers
Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS)
|Journal of Clinical Oncology|2011|1.6k
Cellular zinc metabolism and zinc signaling: from biological functions to diseases and therapeutic targets
|Signal Transduction and Targeted Therapy|2024|316
Modular enzyme assembly for enhanced cascade biocatalysis and metabolic flux
|Nature Communications|2019|284
N6-Methyladenosine Reader YTHDF1 Promotes ARHGEF2 Translation and RhoA Signaling in Colorectal Cancer
|Gastroenterology|2021|182